Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study-Reference-Cited by-同舟云学术

Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study

Published:2014-12-21 Issue:2 Volume:30 Page:131-141
ISSN:0393-2990
Container-title:European Journal of Epidemiology
language:en
Short-container-title:Eur J Epidemiol

Author:

di Giuseppe Romina,Kühn Tilmann,Hirche Frank,Buijsse Brian,Dierkes Jutta,Fritsche Andreas,Kaaks Rudolf,Boeing Heiner,Stangl Gabriele I.,Weikert Cornelia

Publisher

Springer Science and Business Media LLC

Subject

Epidemiology

Link

http://link.springer.com/content/pdf/10.1007/s10654-014-9982-4.pdf

Reference47 articles.

1. Quarles LD. The bone and beyond: ‘Dem bones’ are made for more than walking. Nat Med. 2011;17(4):428–30. doi: 10.1038/nm0411-428 .

2. Hori M, Shimizu Y, Fukumoto S. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology. 2011;152(1):4–10. doi: 10.1210/en.2010-0800 .

3. Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol. 2007;195(1):125–31.

4. Kovesdy CP, Quarles LD. Fibroblast growth factor-23: what we know, what we don’t know, and what we need to know. Nephrol Dial Transplant. 2013. doi: 10.1093/ndt/gft065 .

5. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study. Ann Intern Med. 2010;152(10):640–8. doi: 10.1059/0003-4819-152-10-201005180-00004 .

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMP‐dependent kinase stimulates the expression of αKlotho;FEBS Open Bio;2024-08

2. PKC regulates αKlotho gene expression in MDCK and NRK-52E cells;Pflügers Archiv - European Journal of Physiology;2023-09-29

3. Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry;Frontiers in Cardiovascular Medicine;2023-08-04

4. Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells;Scientific Reports;2023-05-24

5. The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells;Frontiers in Endocrinology;2023-03-08